Through association studies, CPS1 polymorphisms have been implicated in coronary artery disease and persistent pulmonary hypertension of the newborn18, possibly by reducing arginine-derived nitric oxide metabolites. The gene discussed is CPS1; the disease is coronary artery disorder.